Evidence map›Paper›PMID 28471419›Full record

ReviewMetabolites2017

Mitochondrial Deficiencies in the Predisposition to Paraganglioma.

Charlotte Lussey-Lepoutre, Alexandre Buffet, Anne-Paule Gimenez-Roqueplo, Judith Favier

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Approach to the Patient With Metastatic Pheochromocytoma and Paraganglioma.The Journal of clinical endocrinology and metabolism · 2025
    Article
  3. Inflammation-induced adrenal dysfunction.Nature reviews. Endocrinology · 2023
    Article
  4. Review
  5. Review
  6. Review
  7. Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain.International journal of molecular sciences · 2021
    Review
  8. Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.Metabolism: clinical and experimental · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Retroperitoneal Leiomyosarcoma From the Radiologic Pathology Archives.Radiographics : a review publication of the Radiological Society of North America, Inc
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Charlotte Lussey-LepoutreINSERM UMR970, Paris-Cardiovascular Research Center at HEGP, F-75015 Paris, France. charlotte.lussey@inserm.fr.
Alexandre BuffetINSERM UMR970, Paris-Cardiovascular Research Center at HEGP, F-75015 Paris, France. alexander.buffet@inserm.fr.
Anne-Paule Gimenez-RoqueploINSERM UMR970, Paris-Cardiovascular Research Center at HEGP, F-75015 Paris, France. anne-paule.gimenez-roqueplo@aphp.fr.
Judith FavierINSERM UMR970, Paris-Cardiovascular Research Center at HEGP, F-75015 Paris, France. judith.favier@inserm.fr.
Délégation Paris 5 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas and pheochromocytomas are rare neuroendocrine tumours with a very strong genetic component. It is estimated that around 40% of all cases are caused by a germline mutation in one of the 13 predisposing genes identified so far. Half of these inherited cases are intriguingly caused by mutations in genes encoding tricarboxylic acid enzymes, namely

Indexed as

paragangliomapheochromocytomaSDH

Identifiers

PMID28471419
PMCPMC5487988
OpenAlexW2610749500

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.